![]() The amount of the filing fee is calculated in accordance with Rule 0-11 GenMark to the offerors and are as of March 19, 2021, the most recent practicable date. The foregoing figures have been provided by ![]() in-the-money) (iii) the product of (A) outstanding restricted stock units in respect of 3,439,519 Shares subject to such restricted stock units (withĪny applicable performance conditions deemed to be achieved at maximum performance) and (B) the Offer Price and (iv) the product of (A) 52,009 Shares which are estimated to be subject to outstanding purchase rights under theĬompanys employee stock purchase price and (B) the Offer Price. Stock options and (B) $12.71, which is the difference between the $24.05 per share tender offer price and $11.34, the average weighted exercise price of such options (all of which are ( GenMark), and (B) $24.05 (the Offer Price) (ii) the product of (A) 693,995 Shares subject to issuance pursuant to outstanding GenMark ( Shares) of common stock of GenMark Diagnostics, Inc. ![]() The Transaction Value was calculated by adding (i) the product of (A) 73,596,658 outstanding shares (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Persons)Įstimated solely for purposes of calculating the filing fee pursuant to RuleĠ-11(d) under the Securities Exchange Act of 1934, as amended (the Exchange Act). Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |